Medicure, Inc. (NASDAQ:MCUJF) | WebDisclosure

Basculer en Français

10144	Companies
208220	Keywords
138261	Articles
110313	Press releases

Home
Companies
Medicure, Inc.

PRESS RELEASE

published on 06/24/2024 at 23:00, 1 year 9 months ago

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use

Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use
BRIEF

published on 05/28/2024 at 23:05, 1 year 10 months ago

Medicure Reports Financial Results for Q1 2024 and Director Election Results

Financial Results Director Election Q1 2024 Medicure
BRIEF

published on 05/28/2024 at 23:05, 1 year 10 months ago

Medicure publie ses résultats financiers pour le premier trimestre 2024 et les résultats de l'élection des administrateurs

Résultats Financiers Médicament T1 2024 Élection Du Directeur
PRESS RELEASE

published on 05/28/2024 at 23:00, 1 year 10 months ago

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed

Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
BRIEF

published on 04/23/2024 at 23:05, 1 year 11 months ago

Medicure reçoit la désignation Fast Track de la FDA pour le traitement MC-1 du déficit en PNPO

Medicure Inc. Désignation De Médicament Orphelin Désignation Fast Track De La FDA MC-1 Carence En PNPO
BRIEF

published on 04/23/2024 at 23:05, 1 year 11 months ago

Medicure Receives FDA Fast Track Designation for MC-1 Treatment for PNPO Deficiency

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency
PRESS RELEASE

published on 04/23/2024 at 23:00, 1 year 11 months ago

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRIEF

published on 04/08/2024 at 23:05, 1 year 11 months ago

Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre

Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
BRIEF

published on 04/08/2024 at 23:05, 1 year 11 months ago

Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance

Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 04/08/2024 at 23:00, 1 year 11 months ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed

Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis

Accesswire

Published on 04/01/2026 at 17:00, 43 minutes ago

Stagwell Announces UNICEPTA UK and Hootsuite Strategic Partnership to Deliver Decision-Grade Media Intelligence Within the Talkwalker Platform
Published on 04/01/2026 at 16:00, 1 hour 43 minutes ago

Norsemont Commences Trading on the OTCQX Market
Published on 04/01/2026 at 15:10, 2 hours 33 minutes ago

A2Z Announces Audited Full-Year 2025 Financial Results
Published on 04/01/2026 at 15:00, 2 hours 43 minutes ago

Karbon-X Named Official Sustainability Partner of the Detroit Red Wings and Detroit Tigers
Published on 04/01/2026 at 14:30, 3 hours 13 minutes ago

Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides

View all ACCESSWIRE

EQS Group

Published on 04/01/2026 at 17:30, 12 minutes ago

Springer Nature’s CFO to leave the company by the end of 2026
Published on 04/01/2026 at 17:27, 16 minutes ago

LION E-Mobility AG: Strong growth and increase in EBITDA in FY 2025
Published on 04/01/2026 at 17:11, 32 minutes ago

Press Release: Leonteq publishes results of its Annual General Meeting 2026
Published on 04/01/2026 at 17:10, 33 minutes ago

CloudM Launches Continuity: Instant M365 Outage Recovery
Published on 04/01/2026 at 16:24, 1 hour 18 minutes ago

Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission (as amended or replaced from time

Les Echos

Published on 04/01/2026 at 17:37, 6 minutes ago

Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
Published on 04/01/2026 at 17:37, 6 minutes ago

Mise à disposition du rapport sur les paiements faits aux gouvernements prévu à l’article L.225-102-3 du Code de commerce
Published on 04/01/2026 at 17:35, 8 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 23 au 31 mars 2026
Published on 04/01/2026 at 17:35, 8 minutes ago

Disclosure of transactions in own shares from March 23 to March 31, 2026
Published on 04/01/2026 at 08:00, 9 hours 43 minutes ago

Transfert du contrat de liquidité aupres de Natixis Oddo BHF

View all LES ECHOS COMFI WIRE